Scientists ask: Without trial data, how can we trust Russia's COVID vaccine?


  • World
  • Tuesday, 11 Aug 2020

A scientist works inside a laboratory of the Gamaleya Research Institute of Epidemiology and Microbiology during the production and laboratory testing of a vaccine against the coronavirus disease (COVID-19), in Moscow, Russia August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS

LONDON (Reuters) - An announcement by Russia on Tuesday that it will approve a COVID-19 vaccine after less than two months of human testing prompted alarm among global health experts, who said that with no full trial data, the vaccine is hard to trust.

Intent on being first in the global race to develop a vaccine against the pandemic disease, Russia has yet to conduct large-scale trials of the shot that would produce data to show whether it works - something immunologists and infectious disease experts say could be a "reckless" step.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Thai court rejects petition over ex-PM Thaksin's political influence
Taiwan's president to visit Tuvalu, Palau and Marshall Islands
US believes Russia's attack in Ukraine showcased new missile
Haiti blasts Macron's criticism of transition council as 'unfriendly and inappropriate'
Cote d'Ivoire, EU sign new fishing agreement
North Korea's Kim accuses US of stoking tension, warns of nuclear war
Canada to give holiday tax break for groceries
U.S. stocks close higher
Slovak PM shooting suspect faces prolonged custody
Gas Leak prompts evacuation of 150 people in Prague

Others Also Read